GO 7716
Latest Information Update: 19 Oct 2000
Price :
$50 *
At a glance
- Originator Goedecke
- Class Antivirals
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Oct 2000 Discontinued-Unspecified phase in HIV infections treatment in Germany (Unknown route)
- 18 Jan 1996 No-Development-Reported for HIV infections treatment in Germany (Unknown route)